(Q34642037)

3 August 2017

title

Whole-organism high-throughput screening against Trypanosoma brucei brucei (English)

1 reference

3 August 2017

0 references

Vicky M Avery

2

0 references

author name string

Amy J Jones

series ordinal

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

31 March 2013

1 reference

Expert Opinion on Drug Discovery

3 August 2017

published in

1 reference

3 August 2017

volume

8

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

495-507

1 reference

Estimating and mapping the population at risk of sleeping sickness

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

The epidemiology and control of human African trypanosomiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Developmental cycles and biology of pathogenic trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Transitory neurological signs in sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Why trypanosomes cause sleeping sickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Trypanosoma brucei and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Eliminating human African trypanosomiasis: where do we stand and what comes next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A drug incubation infectivity test (DIIT) for assessing resistance in trypanosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Cysteine eliminates the feeder cell requirement for cultivation of Trypanosoma brucei bloodstream forms in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

In vitro drug sensitivity test for Trypanosoma brucei subgroup bloodstream trypomastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Pyrimidine salvage in Trypanosoma brucei bloodstream forms and the trypanocidal action of halogenated pyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Purine and pyrimidine metabolism in the Trypanosomatidae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A new photometric assay for testing trypanocidal activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

The catabolism of glucose by strains of Trypanosoma rhodesiense

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Drug cytotoxicity assay for African trypanosomes and Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Quantification of mitogen induced human lymphocyte proliferation: comparison of alamarBlue assay to 3H-thymidine incorporation assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Trypanosoma (Nannomonas) congolense: Changes in respiratory metabolism during the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Alternative statistical parameter for high-throughput screening assay quality assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Mechanism of oxidation in firefly luminescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A static-cidal assay for Trypanosoma brucei to aid hit prioritisation for progression into drug discovery programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Quinol derivatives as potential trypanocidal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

2,4-Diaminopyrimidines as potent inhibitors of Trypanosoma brucei and identification of molecular targets by a chemical proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Antitumor quinol PMX464 is a cytocidal anti-trypanosomal inhibitor targeting trypanothione metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

N-myristoyltransferase inhibitors as new leads to treat sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

In vitro trypanocidal activity of the anti-helminthic drug niclosamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Hit-to-lead development of the chamigrane endoperoxide merulin A for the treatment of African sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Natural product libraries to accelerate the high-throughput discovery of therapeutic leads

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Antitrypanosomal activity of some medicinal plants from Nigerian ethnomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Inhibitory activity of marine sponge-derived natural products against parasitic protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Iotrochamides A and B, antitrypanosomal compounds from the Australian marine sponge Iotrochota sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Convolutamines I and J, antitrypanosomal alkaloids from the bryozoan Amathia tortusa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

7',8'-Dihydroobolactone, a typanocidal alpha-pyrone from the rainforest tree Cryptocarya obovata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Antitrypanosomal cyclic polyketide peroxides from the Australian marine sponge Plakortis sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Discovery of novel benzoxaborole-based potent antitrypanosomal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

A molecular mechanism for eflornithine resistance in African trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Anti-African trypanocidal and antimalarial activity of natural flavonoids, dibenzoylmethanes and synthetic analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

Antitrypanosomal pyridoacridine alkaloids from the Australian ascidian Polysyncraton echinatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2013.783816

10.1517/17460441.2013.783816

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference